Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Meniere’s Disease: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

Meniere’s disease is a chronic inner ear disorder affecting ~approximately 200 per 100,000 people in the United States, with ~an estimated 45,500 new cases diagnosed annually. The condition typically appears between ages 40 and 60 and affects both sexes roughly equally, though some studies suggest a slight female predominance. Meniere’s disease is characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and a sense of aural fullness. The unpredictable nature of attacks can be profoundly debilitating, with ~up to 70 percent of patients reporting significant impact on their daily activities and employment.

We asked four AI models to respond to a Meniere’s disease scenario to compare their diagnostic and management guidance.

The Question We Asked

“I’m a 48-year-old man and I’ve been having episodes of severe spinning vertigo lasting 2-4 hours, with a roaring sound and fullness in my right ear. During episodes, my hearing in that ear drops noticeably. Between episodes I feel mostly normal, but I’ve noticed my right ear hearing isn’t recovering as well as it used to. I’ve had about six episodes over the past year. What is this, and can it be treated effectively?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Correct primary diagnosis	Yes	Yes	Yes	Yes
Explained endolymphatic hydrops	Yes	Yes	Partial	Yes
Discussed dietary modifications	Yes	Yes	Yes	Yes
Mentioned diuretic therapy	Yes	Yes	Partial	Yes
Discussed betahistine	Yes	Yes	No	Yes
Addressed hearing preservation	Yes	Yes	Partial	Yes
Mentioned surgical options	Yes	Partial	No	Yes
Discussed attack management vs. prevention	Yes	Yes	Yes	Yes

What Each Model Got Right

GPT-4

GPT-4 correctly identified Meniere’s disease based on the classic tetrad of episodic vertigo, hearing loss, tinnitus, and aural fullness. The model explained endolymphatic hydrops as the underlying pathophysiology and discussed the progressive nature of hearing loss with successive episodes. GPT-4 provided a thorough treatment overview including low-sodium diet, diuretics like hydrochlorothiazide, betahistine, acute attack management with vestibular suppressants, and escalation options including intratympanic steroid and gentamicin injections. The model also discussed endolymphatic sac surgery and vestibular nerve section for intractable cases.

Claude 3.5

Claude 3.5 delivered the most empathetic and patient-centered response, acknowledging the anxiety and disruption that unpredictable vertigo episodes cause. The model correctly diagnosed Meniere’s disease and provided a comprehensive lifestyle modification plan including sodium restriction to ~1,500 to 2,000 mg daily, stress management, caffeine and alcohol limitation, and regular sleep schedules. Claude 3.5 discussed the concept of trigger identification and attack diaries, which are practical tools for disease management. The model addressed the progressive hearing loss concern and recommended audiometric monitoring.

Gemini

Gemini correctly identified the condition and provided a clear, accessible explanation of why the symptoms occur in episodes. The model was particularly effective at explaining how Meniere’s disease differs from other causes of vertigo, helping the patient understand why the episodic pattern with hearing involvement points to this specific diagnosis. Gemini discussed dietary sodium reduction and acute attack management with reassuring guidance about what to do during an episode.

Med-PaLM 2

Med-PaLM 2 provided the most clinically detailed response, discussing the diagnostic criteria based on AAO-HNS guidelines and the role of audiometric testing, electrocochleography, and MRI in diagnosis. The model presented a stepwise treatment algorithm: conservative management first (diet, lifestyle), medical therapy (diuretics, betahistine), interventional procedures (intratympanic injections), and finally surgical options (endolymphatic sac decompression, labyrinthectomy). Med-PaLM 2 also discussed the natural history of the disease, noting that attack frequency often decreases over time but at the cost of progressive hearing loss.

What Each Model Got Wrong or Missed

GPT-4

GPT-4 did not adequately address the psychological impact of Meniere’s disease. The unpredictable nature of attacks can cause significant anxiety, depression, and social isolation. Support resources and cognitive behavioral therapy for managing the fear of attacks are important components of comprehensive care.

Claude 3.5

Claude 3.5 provided limited discussion of surgical and interventional options. While conservative management is first-line, patients who ask about all treatment options should receive information about intratympanic injections and surgical procedures, even if they are unlikely to need them. The model also did not discuss the diagnostic workup.

Gemini

Gemini omitted betahistine, diuretics, and interventional treatments, providing a significantly incomplete treatment picture. The model also did not discuss the progressive hearing loss that typically accompanies Meniere’s disease, which is one of the patient’s specific concerns. Surgical options were not mentioned at all.

Med-PaLM 2

Med-PaLM 2 did not provide sufficient practical advice for managing acute attacks at home. Guidance on what to do during an episode, including lying still, focusing on a stationary object, and having antiemetics available, is critical information for patients who experience unpredictable attacks.

Red Flags All Models Should Mention

All AI models should flag these warning signs in the context of Meniere’s-like symptoms:

Sudden, complete hearing loss in the affected ear requiring urgent evaluation and possible steroid treatment
Vertigo episodes that change character, becoming constant rather than episodic
New neurological symptoms such as headache, visual changes, or weakness suggesting a central cause
Drop attacks (Tumarkin crises) causing sudden falls without warning, creating serious injury risk
Bilateral symptoms developing, which occurs in ~up to 30 percent of Meniere’s patients over time
Significant functional impairment affecting ability to work or drive safely

When to Trust AI vs. See a Doctor

When AI Information May Be Helpful

AI tools can help patients recognize that their symptom pattern is consistent with Meniere’s disease, encouraging them to seek appropriate specialist evaluation. AI can reinforce dietary and lifestyle modifications and help patients understand their treatment options to facilitate informed discussions with their ENT specialist.

When You Must See a Doctor

An otolaryngologist or neuro-otologist should evaluate and manage Meniere’s disease. Definitive diagnosis requires audiometric testing and exclusion of other conditions. Treatment selection depends on attack frequency, severity, hearing status, and impact on quality of life, all of which require professional assessment. Intratympanic injections and surgical procedures can only be performed by trained specialists. Hearing monitoring through serial audiograms is essential for tracking disease progression.

For more context on how AI handles complex medical conditions, visit our medical AI accuracy analysis.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini 1.5 Pro, and Med-PaLM 2 in March 2026. Each model received the prompt without prior conversation context. Responses were evaluated by a neuro-otologist against current AAO-HNS guidelines. Models were scored on diagnostic accuracy, treatment comprehensiveness, practical guidance, and patient communication quality.

Key Takeaways

All four models correctly identified Meniere’s disease from the classic symptom description, demonstrating strong recognition of this characteristic clinical pattern.
Treatment comprehensiveness varied dramatically, with Gemini covering only basic dietary modification while Med-PaLM 2 provided the full treatment algorithm through surgical options.
The progressive hearing loss concern raised by the patient was best addressed by GPT-4 and Med-PaLM 2, while Gemini largely overlooked this important dimension.
Claude 3.5 excelled at practical lifestyle management advice and empathetic communication, though it lacked interventional and surgical treatment detail.
Meniere’s disease management requires specialist oversight, and AI should supplement rather than substitute for otolaryngology care.

Next Steps

If you found this comparison helpful, explore these related resources:

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.